http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2170084-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b45bd6a1d0ee80dd6c136c259ec7867a
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 2000-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2001-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd10e153e7495f38574eb86ceedecbac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88b82ead7f74c31fb779e0faec8aa49e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e28025b6f85fff9607474caae901cac
publicationDate 2001-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2170084-C1
titleOfInvention Method of dna tablet making
abstract FIELD: medicine, pharmaceutical industry. SUBSTANCE: lyophilically dried DNA preparation obtained from salmon and sturgeon fish milts is mixed with filling agent consisting of microcrystalline cellulose and potato starch or lactose. Mixture is tableted and tablets are covered by envelope consisting of acetylphthalylcellulose in the following ratio of components, weight %: DNA, 22-23; micro-crystalline cellulose, 37-38; potato starch or lactose, 37-38; acetylphthalylcellulose, 1.5-2.3. EFFECT: improved consumers' properties, enhanced facility of preparation using. 2 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9904734-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10920274-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9297032-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9790538-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10519605-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10047282-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8420400-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8124333-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8426216-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8415164-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8415165-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9919512-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10995371-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9290819-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8669079-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10760182-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9963740-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8372648-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10282480-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10745825-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8940485-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10741034-B2
priorityDate 2000-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62698
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID61674
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID61674
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526466

Total number of triples: 43.